Skip to main content
. 2025 Aug 11;16:1644051. doi: 10.3389/fmicb.2025.1644051

Table 2.

MIC50, MIC90 of tested C. difficile strains.

Antibiotic MIC50 MIC90 Strains resistant Breakpoints used [mg/L]
n = 130 %
Metronidazolea 1 2 5 4 S ≤ 2, R > 2
Vancomycina 0.38 0.5 0 0 S ≤ 2, R > 2
Erythromycinb 256 256 87 67 R > 256
Clindamycind 8 256 128 98 S ≤ 0.25, R > 0.25
Moxifloxacinc 32 32 130 100 4
Rifampicinc 32 32 83 64 0.004
Piperacillin/Tazobactamd 3 6 129 99 S ≤ 0.5, R > 0.5
Imipenemd 32 32 129 99 S ≤ 0.5, R > 0.5
Benzylpenicillind 1 2 108 83 S ≤ 0.5, R > 0.5
Chloramphenicole 6 12 17 13 S ≤ 8, R > 8
a

Resistance according to EUCAST (v.15 2024).

b

Assumed R > 256 mg/L.

c

ECOFF for C. difficile was used.

d

MICs for C. perfringens according to EUCAST 2024.

e

MICs for Gram-positive anaerobes were used because lack of them according EUCAST (v.11).